Insider Stock Trading History of Slansky Richard B


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Slansky Richard B since year 2005. The trader's CIK number is 1224981. At the time of this reporting, Slansky Richard B is the Chief Financial Officer of Oncosec Medical Inc . (stock ticker symbol ONCS.D). See this page for all insider trading activities at Oncosec Medical Inc .

Note that in the past SLANSKY RICHARD B also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Slansky Richard B since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2015-07-06 ONCS Oncosec Medical Inc Buy 150,000 6.12 918,000
2014-05-08 GNMK Genmark Diagnostics, Inc. Sale 2,302 9.26 21,318
2014-03-11 GNMK Genmark Diagnostics, Inc. Sale 1,680 12.17 20,438
2014-02-07 GNMK Genmark Diagnostics, Inc. Sale 838 12.29 10,302
2013-11-06 GNMK Genmark Diagnostics, Inc. Sale 660 11.72 7,735
2012-06-26 GNMK Genmark Diagnostics, Inc. Buy 25,000 4.20 105,000
2012-04-10 DRAD Digirad Corp Option Ex 2,732 .00 0
2012-04-10 DRAD Digirad Corp Option Ex 2,732 .00 0
2012-01-17 DRAD Digirad Corp Option Ex 2,954 .00 0
2011-10-11 DRAD Digirad Corp Option Ex 2,550 .00 0
2011-07-14 DRAD Digirad Corp Option Ex 2,455 .00 0
2011-04-25 DRAD Digirad Corp Option Ex 1,102 .00 0
2011-01-18 DRAD Digirad Corp Option Ex 2,838 .00 0
2010-10-11 DRAD Digirad Corp Option Ex 1,095 .00 0
2010-08-09 DRAD Digirad Corp Option Ex 1,255 .00 0
2010-06-25 DRAD Digirad Corp Option Ex 1,065 .00 0

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Slansky Richard B (Chief Financial Officer of Oncosec Medical Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.